Asuragen, Inc.
Asuragen, Inc. Launches Signature NPM1 Mutations RUO*: a Rapid Multiplex Assay for the Detection of NPM1 Mutations
Published in Genetics and Environmental Business Week, September 4th, 2008
Asuragen, Inc. announced the launch of Signature(R) NPM1 Mutations (RUO), a multiplex reverse transcription PCR (RT-PCR) assay that enables the detection of NPM1 mutations. Asuragen's Signature(R) NPM1 Mutations is a sensitive molecular assay for the combined detection of mutations A, B and D in exon 12 of the nucleophosmin (NPM1) gene. Asuragen is one of two exclusive licensees to NPM1. The assay is performed on the Luminex(R) 100(TM) IS or 200(TM) System using a liquid bead array method. The liquid bead array format provides comprehensive information in a single well, providing efficiency and cost benefits to the laboratory.
Signature(R) NPM1 Mutations can be used for...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Business Week
More Articles from Genetics and Environmental Business Week
- Acrongenomics, Inc.
Acrongenomics Increases its Shareholding in and Restructures Relationship with Molecular Vision - Alzheimer Disease
Alzheimer's Disease and Emerging Treatments Analyzed in Neurotech Insights - Apoptosis
AposenseŽ [18f]-ml-10 To Be Radiolabelled By Iba for Multi-center Clinical Trials - Ataxia
Boston University and the Center for Human Genetics, Inc. Announce Change in Testing Services - BioTime, Inc.
BioTime, Inc.'s Subsidiary, Embryome Sciences, Inc., Licenses Virus-Free iPS and Embryonic Stem Cell Differentiation Technology - Cancer
New cancer study findings have been reported by researchers at Boehringer Ingelheim GmbH - More from this issue of Genetics and Environmental Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
